European journal of medical research,
Год журнала:
2024,
Номер
29(1)
Опубликована: Окт. 22, 2024
In
addition
to
the
persistence
of
SARS-CoV-2
infections,
those
with
Influenza
A/B
and
RSV
have
reappeared
in
2022/23.
To
compare
development
prevalence,
clinical
outcomes
risk
factors,
we
analysed
data
season
2023/24
from
same
region/hospital
as
for
Patients
covering
whole
age
range
a
positive
polymerase
chain
reaction
(PCR)
test
SARS-CoV-2,
A/B,
were
included
internal,
neurological
paediatric
units
RoMed
hospital
Rosenheim,
Germany/Bavaria,
August
1st
2023
29th
February
2024.
Of
932
patients
included,
912
showed
single
infections
A
or
(47.9%
female,
median
68.0
years;
52.9%
23.2%
A,
21.8%
RSV).
Co-infections
(2.0%)
B
(0.1%)
negligible.
≥
18
years
(n
=
628,
68.5%
26.0%
5.6%
RSV),
younger
compared
(p
<
0.001),
similar
SARS-CoV-2.
Heart
failure
asthma
most
prevalent
comorbidities
RSV,
immunosuppression
A.
Admission
Intensive
Care
Unit
(ICU)
occurred
111
(17.0%
17.2%
28.6%
59
died
(8.8%
8.6%
20.0%
Low-flow
oxygen
supplementation
non-invasive
ventilation
(NIV)
frequent
(68.6%
20.0%,
respectively),
demand
upon
admission
(39.3%),
without
differences
high-flow
supply
length
stay.
Among
aged
284,
21.4%
18.0%
57.1%
15
admitted
ICU
(4.8%
3.8%
6.0%
RSV);
none
them
died.
Oxygen
via
high-flow,
low-flow
was
highest
(23.8%,
70.2%,
21.4%,
well
Between
8/2023
2/2024,
large
population
hospitalized
due
respiratory
tract
infection,
relative
contributions
The
findings
underline
that
both,
adults
children,
posed
relatively
higher
than
though
absolute
numbers
remained
Infectious Diseases,
Год журнала:
2024,
Номер
unknown, С. 1 - 8
Опубликована: Сен. 16, 2024
Because
patients
infected
with
respiratory
syncytial
virus
(RSV)
have
been
reported
to
be
older
than
influenza
virus,
the
more
frequent
incidence
of
complications
in
RSV-infected
may
age-related.
This
study
compared
clinical
characteristics
and
outcomes
hospitalized
adults
RSV
findings
age-
sex-matched
virus.
Journal of Infection,
Год журнала:
2024,
Номер
89(5), С. 106292 - 106292
Опубликована: Сен. 26, 2024
Our
aim
was
to
estimate
the
risk
of
pneumonia,
admission
intensive
care
unit
(ICU)
or
death
in
individuals
≥65
years
old
admitted
hospital
with
RSV,
compared
influenza
COVID-19.
Global Heart,
Год журнала:
2024,
Номер
19(1), С. 78 - 78
Опубликована: Окт. 15, 2024
Infections,
particularly
those
involving
the
respiratory
tract,
are
associated
with
an
increased
incidence
of
cardiovascular
events,
both
de
novo
and
as
exacerbations
pre-existing
diseases.
Influenza
vaccination
has
consistently
been
shown
to
reduce
events.
Nonetheless,
rates
among
adults
remain
suboptimal,
in
general
population
high-risk
individuals.
Multiple
barriers
hinder
achieving
adequate
rates,
physicians'
beliefs
attitudes
towards
these
interventions
being
crucial.
The
FLUence
project
was
developed
within
framework
World
Heart
Federation's
Emerging
Leaders
program,
address
this
issue.
This
two
phases:
a
global
quantitative
survey
assess
perceptions,
opinions,
challenges
physicians
worldwide
regarding
safety
efficacy
influenza
use,
qualitative
further
investigate
facilitators
recommending
using
vaccination.
created
disseminated
five
languages
(English,
Spanish,
French,
Italian,
Portuguese)
all
specialties
who
care
for
adults,
particular
focus
on
patients
disease.
included
eight
domains
total
36
questions
closed
options;
Likert
scale
possible
answers
used
gauge
participants'
opinions.
To
gain
deeper
insights
into
complexities
behind
low
second
part
comprises
survey,
conducted
lower-middle-
upper-middle-income
countries:
India
Argentina,
respectively.
These
countries
were
selected
because
diseases
have
access
free
whereas
must
pay
vaccine
out
pocket
India.
Thus,
study
will
provide
valuable
information
better
understand
perceptions
improving
from
perspective
physicians.
It
is
imperative
actively
engage
healthcare
providers
improve
rates.
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 15, 2024
Abstract
Background
In
addition
to
the
persistence
of
SARS-CoV-2
infections,
those
with
Influenza
A/B
and
RSV
have
reappeared
in
2022/23.
To
compare
development
prevalence,
clinical
outcomes
risk
factors,
we
analysed
data
season
2023/24
from
same
region/hospital
as
for
Methods
Patients
covering
whole
age
range
a
positive
polymerase
chain
reaction
(PCR)
test
SARS-CoV-2,
A/B,
were
included
internal,
neurological
paediatric
units
RoMed
hospital
Rosenheim,
Germany/Bavaria,
August
1st
2023
29th
February
2024.
Results
Of
932
patients
included,
912
showed
single
infections
A
or
(47.9%
female,
median
68.0
years;
52.9%
23.2%
A,
21.8%
RSV).
Co-infections
(2.0%)
B
(0.1%)
negligible.
≥
18
years
(n
=
628,
68.5%
26.0%
5.6%
RSV),
younger
compared
(p
<
0.001),
similar
SARS-CoV-2.
Heart
failure
asthma
most
prevalent
comorbidities
RSV,
immunosuppression
A.
Admission
Intensive
Care
Unit
(ICU)
occurred
111
(17.0%
17.2%
28.6%
59
died
(8.8%
8.6%
20.0%
Low-flow
oxygen
supplementation
non-invasive
ventilation
(NIV)
frequent
(68.6%
20.0%,
respectively),
demand
upon
admission
(39.3%),
without
differences
high-flow
supply
length
stay.
Among
aged
284,
21.4%
18.0%
57.1%
15
admitted
ICU
(4.8%
3.8%
6.0%
RSV);
none
them
died.
Oxygen
via
high-flow,
low-flow
was
highest
(23.8%,
70.2%,
21.4%,
well
Conclusion
2023/24,
large
population
hospitalized
due
respiratory
tract
infection,
relative
contributions
The
findings
underline
that
both,
adults
children,
posed
relatively
higher
than
though
absolute
numbers
remained
European journal of medical research,
Год журнала:
2024,
Номер
29(1)
Опубликована: Окт. 22, 2024
In
addition
to
the
persistence
of
SARS-CoV-2
infections,
those
with
Influenza
A/B
and
RSV
have
reappeared
in
2022/23.
To
compare
development
prevalence,
clinical
outcomes
risk
factors,
we
analysed
data
season
2023/24
from
same
region/hospital
as
for
Patients
covering
whole
age
range
a
positive
polymerase
chain
reaction
(PCR)
test
SARS-CoV-2,
A/B,
were
included
internal,
neurological
paediatric
units
RoMed
hospital
Rosenheim,
Germany/Bavaria,
August
1st
2023
29th
February
2024.
Of
932
patients
included,
912
showed
single
infections
A
or
(47.9%
female,
median
68.0
years;
52.9%
23.2%
A,
21.8%
RSV).
Co-infections
(2.0%)
B
(0.1%)
negligible.
≥
18
years
(n
=
628,
68.5%
26.0%
5.6%
RSV),
younger
compared
(p
<
0.001),
similar
SARS-CoV-2.
Heart
failure
asthma
most
prevalent
comorbidities
RSV,
immunosuppression
A.
Admission
Intensive
Care
Unit
(ICU)
occurred
111
(17.0%
17.2%
28.6%
59
died
(8.8%
8.6%
20.0%
Low-flow
oxygen
supplementation
non-invasive
ventilation
(NIV)
frequent
(68.6%
20.0%,
respectively),
demand
upon
admission
(39.3%),
without
differences
high-flow
supply
length
stay.
Among
aged
284,
21.4%
18.0%
57.1%
15
admitted
ICU
(4.8%
3.8%
6.0%
RSV);
none
them
died.
Oxygen
via
high-flow,
low-flow
was
highest
(23.8%,
70.2%,
21.4%,
well
Between
8/2023
2/2024,
large
population
hospitalized
due
respiratory
tract
infection,
relative
contributions
The
findings
underline
that
both,
adults
children,
posed
relatively
higher
than
though
absolute
numbers
remained
